Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.
By S. Arcasoy, J. Christie, V. Ferrari, M. Sutton, D. Zisman, N. Blumenthal, A. Pochettino, R. Kotloff. American Journal of Respiratory and Critical Care Medicine, 2003
912 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/b7161e24dfb8ee042cb1424e8957bdc5dc428d59
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- S. Abman
- A. Wells
- K. Stenmark
- S. Archer
- N. Hirani
- G. Hansmann
- B. Thébaud
- D. Ivy
Citations in the corpus
- Interstitial lung disease guideline (2008, background): “10 mm Hg) between TTE and right heart catheter measurement of systolic PAP is not uncommon.(632) The specificity and positive predictive value of TTE can be increased if a higher threshold of systolic PAP measurement is adopted; in patients with SSc, including”
- Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society (2015, background): “Factors associated with chronic lung disease, specifically marked pulmonary hyperinflation, expansion of the thoracic cage, and alteration of the position of the heart, adversely affect the ability to detect and measure TR jet velocities.(278) Thus, as used in clinical practice, echocardiography oft”